CapeRay has its origins in a joint venture between De Beers and the University of Cape Town 12 years ago when we received $1.5m in funding from the Innovation Fund, an initiative of the South African government, to develop medical applications for low dose X-rays. A competitive grant of $275,000 was subsequently secured from the National Institutes of Health in the USA in 2005 to adapt slot scanning digital X-rays for detecting breast cancer. Then in 2009 CapeRay’s management team negotiated an investment of $2m in venture capital from the Industrial Development Corporation to begin commercialisation.
For the past three years we have worked diligently to bring our PantoScanner product to market, and in July 2012 we received ISO 9001 and ISO 14385 certification and were awarded the CE Mark for our Pandia product. We have recently embarked on our fourth round of fund raising to complete the commercialisation of our PantoScanner range of products. If you would like to find out more about the investment opportunities in CapeRay, please do not hesitate to get in touch with our CEO, Kit Vaughan, at the number below or: kit (at) caperay (dot) com.
Tel: + 27 21 702 4299